Cannabis Stocks Retreat On New Rescheduling Order Developments: What's Going On?

By: via Benzinga
The Biden Administration’s plan to reclassify cannabis as a Schedule III drug may be losing momentum following new reports ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.